NASD · Healthcare · Medical Instruments & Supplies · USA
Embecta Corp is a small cap company (market value between $300 million and $2 billion) in the Medical Instruments & Supplies industry.
Intrinsic value, DCF valuation, financial health and value investing analysis for the Embecta Corp stock.
No reliable verdict: intrinsic value $48.64 per share, market price $6.15 (as of 2026-11-17).
Discounting its cash flows would put the shares at $48.64: 8 times the price of $6.15. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.
17 more funds hold it; the full list is part of the paid plan.
All 52 Medical Instruments & Supplies stocks
We do not publish a verdict on EMBC. Discounting its cash flows would put the shares at $48.64: 8 times the price of $6.15. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.
We do not publish one (as of the 2026-11-17 close). Discounting its cash flows would put the shares at $48.64: 8 times the price of $6.15. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.